About

Laurent Vecellio works as a researcher at the Research Centre for Respiratory Diseases (CEPR, Inserm U1100), located in the Medicine faculty of the University of Tours (France). He is also the Scientific Director of Nemera. He obtained his PhD in 2002 and his accreditation to supervise university research in 2007. Dr Vecellio’s research focus is in vitro/in vivo correlation in aerosol drug delivery. He develops nebuliser devices for lung and nasal treatments and manages projects on drug and device development in collaboration with different companies.

Contributions

Figure 2: RetroNose prototype device examples.

RESPIRATORY

DEPOSITION IN THREE NASAL CAST MODELS USING RETRONOSE CONCEPT

Laurent Vecellio, Déborah Le Pennec, Guillaume Grevin and Alain Regard discuss a study conducted to test particle deposition characteristics of the RetroNose device prototype for nasal drug delivery.

More contributions

PULMONARY

GENERIC NEBULISER BIOEQUIVALENCE: OPTIMISING ANALYTICAL STRATEGIES

Déborah Le Pennec, Laurent Vecellio, Paul Kippax and Stephane Rouquette look at the optimal application of laser diffraction and automated imaging within the context of the US FDA guidance for the in vitro demonstration of bioequivalence in a generic nebuliser.

NASAL

SONIC NEBULISATION IN RHINOLOGY

Laurent Vecellio, Sandrine Le Guellec and Gilles Chantrel describe a sonic nasal nebuliser that operates with an acoustic frequency of 100Hz, and clinical studies demonstrating its efficacy in the delivery of treatments for CRS.